DR. MARTIN BURDA SELECT PUBLICATIONS & ABSTRACTS Farmer, Dr. Stacey J. and Burda, Dr. Martin, LLM (2011) "New Opportunities for Challenging the Validity of a US Patent under the "America Invents Act", Journal of the European Patent Institute (epi), 4/2011, pp. 142-147. Burda, Dr. Martin, Grund, Dr. Martin and Farmer, Dr. Stacey (2009) "G2/06: WARF EPO Upholds a Policy of Refusing European Patents for Inventions Covering Products that 'Can only be Obtained' via the Destruction of Human Embryos", Bio-Science Law Review, Vol. 9, Issue 6, pp. 239-242. Burda, Dr. Martin and Grund, Dr. Martin (2009) "Die Patentierbarkeit von Produkten aus menschlichen Embryonen" (The Patentability of Products (obtained) from Human Embryos), BIOspektrum, Vol. 2, 2009, p. 208-209. Dr. Martin Grund and Dr. Martin Burda (2005) “The new German patent law is not a correct implementation of EU directive 98/44/EC.” Bio-Science Law Review, Volume 7, Issue 3. Dr. M. Grund and M. R. Burda, “Welche Folgen hat die Umsetzung der Biopatentrichtlinie auf die Patentierbarkeit biotechnologischer Erfindungen in Deutschland?" BiIOpektrum, 2005. Dandri M, M.R. Burda, Zuckerman DM, Wursthorn K, Matschl U, Pollok JM, Rogiers X, Gocht A, Kock J, Blum HE, von Weizsacker F, Petersen J. “Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes", J. Hepatol. 2005 Jan;42(1):54-60. Cantz, T., D. M. Zuckerman, M. R. Burda, M. Dandri, B. Goricke, S. Thalhammer, W. M. Heckl, M. P. Manns, J. Petersen and M. Ott (2003). "Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG- 2 mice." Am J Pathol 162(1): 37-45. Dandri, M., M. R. Burda, A. Burkle, D. M. Zuckerman, H. Will, C. E. Rogler, H. Greten and J. Petersen (2002). "Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation." Hepatology 35(1): 217-23. van Raaij, M. J., G. Schoehn, M. Jaquinod, K. Ashman, M. R. Burda and S. Miller (2001). "Identification and crystallisation of a heat- and protease-stable fragment of the bacteriophage T4 short tail fibre." Biol Chem., pp 382(7): 1049-55. van Raaij, M. J., G. Schoehn, M. R. Burda and S. Miller (2001). "Crystal structure of a heat and protease-stable part of the bacteriophage T4 short tail fiber." J Mol Biol 314(5): 1137-46. Torok, E., J. M. Pollok, P. X. Ma, C. Vogel, M. Dandri, J. Petersen, M. R. Burda, P. M. Kaufmann, D. Kluth and X. Rogiers (2001). "Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor." Dig Surg 18(3): 196-203. Dandri, M., M. R. Burda, E. Torok, J. M. Pollok, A. Iwanska, G. Sommer, X. Rogiers, C. E. Rogler, S. Gupta, H. Will, H. Greten and J. Petersen (2001). "Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus." Hepatology 33(4): 981-8. (both first authors contributed equally). Dandri, M., M. R. Burda, A. Gocht, E. Torok, J. M. Pollok, C. E. Rogler, H. Will and J. Petersen (2001). "Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation." Hepatology 34(4 Pt 1): 824-33. (both first authors contributed equally). Burda, M. R., S. Gunther, M. Dandri, H. Will and J. Petersen (2001). "Structural and functional heterogeneity of naturally occurring hepatitis B virus variants." Antiviral Res 52(2): 125-38. Dandri, M., M. R. Burda, H. Will and J. Petersen (2000). "Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA." Hepatology 32(1): 139-46. Burda, M. R., I. Hindennach and S. Miller (2000). "Stability of bacteriophage T4 short tail fiber." Biol Chem 381(3): 255-8. Burda, M. R. and S. Miller (1999). "Folding of coliphage T4 short tail fiber in vitro. Analysing the role of a bacteriophage- encoded chaperone." Eur J Biochem 265(2): 771-8. SELECT SPEAKING ENGAGEMENTS Invited Speaker for the "Second Annual Conference on Recombinant Therapeutics" held February 25-27, 2008, Berlin, Germany |
| Grund IP Group ● Nikolaistrasse 15, D-80802, Munich, GERMANY ● FON: + 49 (89) 54 80 19-0 ● FAX: + 49 (89) 54 80 19-10 |
